Republicans Seize on Reports Critiquing FDA to Push for Agency Reforms

STAT, June 15, 2016. Has Congress’s watchdog agency just given Tennessee Senator Lamar Alexander the ammunition he needs to push a stalled biomedical reform through the Senate? The Government Accountability Office on Wednesday issued two critical reports suggesting that the Food and Drug Administration isn’t properly planning how to keep pace with medical science.

Read More »

21st Century Cures Act Nears Passage with Little News Media Scrutiny

Health News Review, June 13, 2016. With the exception of STAT News, a few other mainstream media outlets, and some boosterish op-eds appearing in local papers, the news media haven’t said much about the 21st Century Cures Act over the past 6 months. It’s fair to say most Americans are in the dark about that far-reaching bill passed by the House of Representatives last summer and now winding its way through the Senate.

Read More »

150 Experts Say Olympics Must Be Moved or Postponed Because of Zika

The Washington Post, May 27, 2016. More than 100 prominent physicians, bioethicists and scientists from around the world posted a letter Friday urging World Health Organization Director-General Margaret Chan to exert pressure on Olympic authorities to move the Olympics from Rio de Janeiro or delay the Games because of public health concerns over the Zika virus.

Read More »

Could This Implant Be the New Weapon Against Opioid, Heroin Addiction?

Miami Herald, May 24, 2016. The U.S. Food and Drug Administration is expected to decide this week whether to approve a new weapon in the war against heroin and prescription opioid addiction. The Probuphine implant by Braeburn Pharmaceuticals of Princeton, NJ, would be the first FDA-approved implant for opioid dependence and the longest-acting treatment to address the growing problem.

Read More »

US Healthcare: Power to the Patients?

Financial Times, May 22, 2016. Families of boys suffering from Duchenne muscular dystrophy push for approval of a new medicine because there are no other treatments. But scientists point out that there is no evidence that the drug works. Does it set a dangerous precedent for FDA to approve a new drug based on patients’ claims rather than science?

Read More »